SCHEMBL3207920

SCHEMBL3207920

CS(=O)(=O)N1CCN(c2ccccc2C=O)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.62
SMN1; SMN2 Q16637 4/20 0.62
NPSR1 Q6W5P4 4/20 0.56
KMT2A Q03164 2/20 0.56
HTT P42858 1/20 0.56
MAPK1 P28482 3/20 0.50
HSD17B10 Q99714 2/20 0.50
POLB P06746 2/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
TSHR P16473 2/20 0.47
MAPK10 P53779 1/20 0.47
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ALOX15 P16050 1/20 0.46
MEN1 O00255 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HPGD P15428 2/20 0.44
MCOLN3 Q8TDD5 1/20 0.44
DCTPP1 Q9H773 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27691459 0.81 KMT2A (0.60) ALDH1A1SMN1; SMN2NPSR1KMT2AHTT
SCHEMBL414216 0.80 ADRA2C (0.55) ALDH1A1KMT2AMAPK1POLBLMNA
SCHEMBL31376167 0.80 ADRA2C (0.55) ALDH1A1KMT2AMAPK1POLBLMNA
SCHEMBL28811611 0.79 LTA4H (0.40) ALDH1A1SMN1; SMN2NPSR1KMT2AHTT
SCHEMBL3436309 0.78 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NPSR1KMT2AHTT
Hydrochloric Acid SCHEMBL5154521 0.78 ADRA2C (0.53) ALDH1A1KMT2AMAPK1POLBLMNA
SCHEMBL9565902 0.78 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2NPSR1KMT2AHTT
SCHEMBL16344453 0.78 CYP3A4 (0.56) ALDH1A1SMN1; SMN2KMT2AMAPK1HSD17B10
SCHEMBL23064633 0.77 MEN1 (0.48) ALDH1A1SMN1; SMN2KMT2AMAPK1TSHR
SCHEMBL3220834 0.77 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2KMT2AMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
CN-101558038-B Curcumin derivative TOKYO INST TECH 2013-05-01 CN disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed
CN-101558038-A Novel curcumin derivative TOKYO INST TECH (JP) 2009-10-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 ALDH1A1 253/4885SMN1; SMN2 1023/4885NPSR1 1048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.